Relmada Therapeutics, Inc. RLMD Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s short-term investments?
- Relmada Therapeutics, Inc. (RLMD) reported short-term investments of $224.19M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s short-term investments changed year-over-year?
- Relmada Therapeutics, Inc.'s short-term investments increased by 765.2% year-over-year, from $25.91M to $224.19M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s short-term investments has grown at a -4.8% compound annual growth rate (CAGR), from $114.6M to $89.51M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.